Update COVID-19 Vaccine Administration Codes 0041A and 0042A Age Changed to 12 Years and Older

September 27, 2022

What is New

For dates of service on or after August 19, 2022, the age range changed to 12 years of age and older for the vaccine administration procedure codes 0041A and 0042A for the administration of the first and second dose of the Novavax COVID-19 vaccine.

Vaccine procedure code 91304 is informational only, while the vaccine is distributed to the provider free of charge.

Reimbursement

We won't reimburse for Novavax COVID-19 vaccines that providers received for free. Providers should not charge members for the vaccine. We will reimburse for the administration of the vaccine. Other medically necessary treatment for COVID-19 will be covered consistent with the terms of the member's benefit plan. You can also reference the CMS Medicaid toolkit for more details.

Claims Reprocessing

Claims with procedure codes 0041A and 0042A with dates of service on or after August 19, 2022 must be reprocessed for appropriate payment. Blue Cross and Blue Shield of Texas (BCBSTX) does not require providers to submit an appeal unless they are denied for other reasons after the claims reprocessing is complete.

Vaccine Administration Claims Submission Information:

Vaccine Code

Use

Description

0041A

Admin

Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, for ages 12 years of age and older

0042A

Admin

Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, for ages 12 years of age and older

M0201

Admin (Setting: Home or Residence)

COVID-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only COVID-19 vaccine administration is performed at the patient's home, for ages 12 years of age and older

91304

Vaccine

Information Only

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use for ages 12 years of age and older

Resources

Providers interested in enrolling as COVID-19 vaccinators

COVID-19 Update to Novavax COVID-19 Vaccine Adjuvanted

CMS Medicaid Toolkit - Coverage and Reimbursement of COVID-19 Vaccines, Vaccine Administration and Cost Sharing under Medicaid, the Children’s Health Insurance Program, and Basic Health Program

Questions

Providers, for questions or additional information, please:

The above material is for informational purposes only and is not a substitute for the independent medical judgment of a physician or other health care provider. Physicians and other health care providers are encouraged to use their own medical judgment based upon all available information and the condition of the patient in determining the appropriate course of treatment. References to other third-party sources or organizations are not a representation, warranty or endorsement of such organization. Any questions regarding those organizations should be addressed to them directly. The fact that a service or treatment is described in this material is not a guarantee that the service or treatment is a covered benefit and members should refer to their certificate of coverage for more details, including benefits, limitations and exclusions. Regardless of benefits, the final decision about any service or treatment is between the member and their health care provider.